NeuroStar ® Advanced Therapy for Mental Health is the leading non-drug, non-invasive, transcranial magnetic stimulation (TMS) treatment for depression. "NeuroStar is delighted to be partnering with Dr. Melissa Shepard to educate those suffering with major depression, their loved ones, and healthcare professionals about our breakthrough technology during National Depression Education and Awareness Month," said Keith J. Sullivan, President and CEO of Neuronetics. "Dr. Shepard shares our passion for helping transform lives; this partnership and the accompanying campaign will help patients and physicians see how conquering depression can become a reality." Dr. Melissa Shepard is a board-certified psychiatrist, psychotherapist, and assistant professor at Johns Hopkins School of Medicine. She and NeuroStar are collaborating to kick off an education and awareness campaign.